Retour sur lavenir.net
   DEME GROUP 184.600 € (-0,22 %)     GBL 80.450 € (+0,31 %)     KBC 114.550 € (-0,78 %)     AB INBEV 61.920 € (-0,32 %)     VASTNED 30.350 € (-0,33 %)     SOFINA 221.200 € (-0,98 %)     WDP 23.900 € (-0,08 %)     RECTICEL 10.240 € (+1,19 %)     D'IETEREN GROUP 176.900 € (-1,72 %)     TESSENDERLO 21.050 € (-0,94 %)     BIOTALYS 2.230 € (0,00 %)     BIOSENIC 0.002 € (0,00 %)     MELEXIS 68.650 € (+4,25 %)     NYRSTAR 0.085 € (+2,41 %)     NYXOAH 2.640 € (-5,38 %)     TINC 11.860 € (-0,34 %)     AZELIS GROUP 10.350 € (-0,38 %)     ORANGE BELGIUM 21.000 € (+2,44 %)     ECONOCOM GROUP 1.475 € (-1,01 %)     VGP 91.100 € (-1,30 %)     BPOST 1.900 € (+0,85 %)     BREDERODE 102.600 € (-0,77 %)     FAGRON 23.600 € (-1,26 %)     BEKAERT 41.950 € (+0,72 %)     DECEUNINCK 2.175 € (+2,11 %)     HOME INVEST BE. 19.020 € (-0,63 %)     AEDIFICA 72.800 € (-1,22 %)     CAMPINE 218.000 € (-0,46 %)     COFINIMMO 84.800 € (-1,74 %)     VIOHALCO 14.200 € (-0,70 %)     CMB.TECH 11.120 € (+2,77 %)     JENSEN-GROUP 70.200 € (-0,28 %)     ARGENX SE 685.400 € (+1,03 %)     TITAN S.A. 46.560 € (+0,30 %)     ACKERMANS V.HAAREN 277.200 € (+0,29 %)     KBC ANCORA 77.300 € (-0,90 %)     OPTION 6.300 € (0,00 %)     UCB 246.300 € (+1,32 %)     XIOR 27.500 € (0,00 %)     CIE BOIS SAUVAGE 325.000 € (+1,56 %)     VAN DE VELDE 32.500 € (+0,62 %)     SHURGARD 26.900 € (-2,36 %)     IMMOBEL 21.500 € (-0,92 %)     TUBIZE-FIN 210.400 € (+0,67 %)     SOLVAY 27.640 € (-0,07 %)     SOLVAC NOM(RETAIL) 74.500 € (+0,68 %)     UMICORE 17.130 € (-1,44 %)     SYENSQO 55.950 € (+1,08 %)     WERELDHAVE BELGIUM 54.000 € (-0,74 %)     FLUXYS BELGIUM D 21.600 € (+0,93 %)     RETAIL ESTATES 69.300 € (-0,14 %)     AGFA-GEVAERT 0.480 € (-0,31 %)     CENERGY 20.800 € (+0,58 %)     AGEAS 67.900 € (-0,22 %)     EVS BROADC.EQUIPM. 36.300 € (-0,95 %)     IBA 14.100 € (-1,26 %)     LOTUS BAKERIES 10 120.000 € (+1,20 %)     PROXIMUS 6.625 € (-0,08 %)     ELIA GROUP 139.600 € (+0,22 %)     ONTEX GROUP 2.980 € (+0,34 %)  
   MAROC TELECOM 9.400 € (0,00 %)     Vusion 147.000 € (+19,03 %)     74SOFTWARE 35.000 € (-0,57 %)     ASM INTERNATIONAL 851.600 € (+1,67 %)     SBM OFFSHORE 35.760 € (+0,56 %)     HAFFNER ENERGY 0.178 € (+72,82 %)     EGIDE 1.280 € (+2,40 %)     CIECHARGEURSINVEST 8.470 € (+0,12 %)     EUROFINS SCIENT. 62.000 € (-1,02 %)     ALSTOM 17.045 € (+0,26 %)     INPOST 15.220 € (+0,13 %)     GROUPE OKWIND 0.830 € (-24,20 %)     KERING 238.150 € (+0,02 %)     UNILEVER 49.055 € (+0,92 %)     INTERPARFUMS 24.000 € (+0,50 %)     HEIJMANS KON 89.400 € (+1,76 %)     L'OREAL 375.850 € (+8,97 %)     STMICROELECTRONICS 42.870 € (+14,44 %)     PHARMING GROUP 1.451 € (+0,62 %)     UNIBAIL-RODAMCO-WE 104.550 € (-0,62 %)     BIC 58.700 € (+1,56 %)     BOOSTHEAT 0.612 € (-12,57 %)     ASML HOLDING 1 223.800 € (-2,08 %)     BE SEMICONDUCTOR 241.800 € (+4,09 %)     SANOFI 81.760 € (+1,21 %)     MICHELIN 32.120 € (+0,82 %)     EURONEXT 145.500 € (-0,14 %)     ARCELORMITTAL SA 51.780 € (-0,92 %)     BASIC-FIT 30.620 € (+2,07 %)     LVMH 475.200 € (+0,19 %)     TOTALENERGIES 76.600 € (+0,76 %)     KENDRION 17.220 € (+2,38 %)     WALLIX 22.400 € (-5,49 %)     EUROPLASMA 0.014 € (-12,20 %)     SECHE ENVIRONNEM. 81.800 € (-1,09 %)     VALEO 11.190 € (+1,50 %)     SCHNEIDER ELECTRIC 274.850 € (+0,35 %)     AKZO NOBEL 52.820 € (-1,34 %)     PLANISWARE 18.240 € (-2,04 %)     CAPGEMINI 100.650 € (-5,71 %)     ALMUNDA PRO NV 1.120 € (+0,90 %)     SARTORIUS STED BIO 157.900 € (-14,18 %)     PROSUS 41.550 € (-2,06 %)     ABN AMRO BANK N.V. 29.600 € (-0,94 %)     ACCOR 43.110 € (-0,48 %)     AMUNDI 77.250 € (0,00 %)     ING GROEP N.V. 24.010 € (-0,58 %)     AALBERTS NV 31.240 € (-0,32 %)     AXA 41.290 € (-0,36 %)     AIRBUS 168.160 € (+1,15 %)     FLOW TRADERS 27.920 € (+0,07 %)     VEOLIA ENVIRON. 35.610 € (+0,94 %)     VALLOUREC 24.870 € (+1,14 %)     AIR LIQUIDE 187.860 € (+0,88 %)     SCOR SE 32.500 € (+0,25 %)     ESSILORLUXOTTICA 191.800 € (-4,81 %)     LEGRAND 150.550 € (+0,64 %)     SAFRAN 279.000 € (+2,39 %)     HEINEKEN 67.480 € (-0,35 %)     PUBLICIS GROUPE SA 77.880 € (-0,76 %)  
News Réglementées
23/04/2026 18:30

Readcrest Capital postpones the publication of its audited consolidated financial statements until mid-May 2026 – Sale of the UK nursing home business requires an adjusted presentation

EQS-News: Readcrest Capital AG / Key word(s): Annual Report
Readcrest Capital postpones the publication of its audited consolidated financial statements until mid-May 2026 – Sale of the UK nursing home business requires an adjusted presentation

23.04.2026 / 18:30 CET/CEST
The issuer is solely responsible for the content of this announcement.


Readcrest Capital postpones the publication of its audited consolidated financial statements until mid-May 2026 – Sale of the UK nursing home business requires an adjusted presentation

Hamburg, April 23, 2026 – Readcrest Capital AG (“the Company”, DE000A0LE3J1; WKN A0LE3J) informs its shareholders that the publication of the audited consolidated financial statements for the 2025 fiscal year has been postponed. The Company’s audited annual financial statements will be published as planned on April 30, 2026; the audited consolidated financial statements are expected to follow on May 21, 2026.

The reason for the postponement is a positive development: the successful sale of the care home business in the United Kingdom, which was closed on April 17, 2026. As a result of this transaction, the affected companies must be reported as discontinued operations in the consolidated financial statements. This means that their earnings contributions must be presented separately and the prior-year figures adjusted accordingly so that shareholders and investors can clearly see the performance of continuing operations. This additional work and its careful review require a little more time.

This results in no changes whatsoever to the company’s operating business or financial position. The postponement is purely technical in nature and does not indicate any issues in the financial statements.

 

Contact
Readcrest Capital AG
Rolf Elgeti, Dr. Marcus Kiefer – Management Board
Schopenstehl 22, D-20095 Hamburg
T: +49 40 679 580-22
M: info@readcrest.com
W: https://www.readcrest.com/

About Readcrest Capital AG
Readcrest Capital AG is a publicly traded company focused on real estate and special-situations investments. The company relies on stable cash flows from systemically important healthcare services in the United Kingdom. Building on this foundation, Readcrest Capital focuses on developing promising residential construction projects in high-growth regions of Germany.



23.04.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language:English
Company:Readcrest Capital AG
Schopenstehl 22
20095 Hamburg
Germany
Phone:+49 (0)40 67958022
E-mail:info@readcrest.com
Internet:www.readcrest.com
ISIN:DE000A0LE3J1
WKN:A0LE3J
Listed:Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Stuttgart, Tradegate BSX
EQS News ID:2313930

 
End of NewsEQS News Service

2313930  23.04.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière